OpenVSafe by OpenVAERS
Search V-safe

DG4-31849-71080

2 vaccinations 2 coded responses 15 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
0-4
ZIP prefix
105 / NY
Registered
2022-06-25
Relationship
Child or adolescent in my care
Guardian
TUQ-28193-00317
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-06-23
    Dose 1 — Moderna
  2. 2022-06-25
    Registered in v-safe
  3. 2022-06-25
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  4. 2022-06-26
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  5. 2022-06-27
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  6. 2022-06-28
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  7. 2022-06-29
    Health check-in — days 1–6 daily, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  8. 2022-06-30
    Health check-in — day 7, dose 1, under 3
    Feeling: Good · None
    Under 3 check-in
  9. 2022-07-07
    Health check-in — day 14, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  10. 2022-07-14
    Health check-in — day 21, dose 1, under 3
    Feeling: Good
    Under 3 check-in
  11. 2022-07-21
    Dose 2 — Moderna
  12. 2022-08-04
    Health check-in — day 14, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  13. 2022-08-11
    Health check-in — day 21, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  14. 2022-08-18
    Health check-in — day 28, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  15. 2022-08-25
    Health check-in — day 35, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  16. 2022-09-01
    Health check-in — day 42, dose 2, under 3
    Feeling: Good
    Under 3 check-in
  17. 2022-10-20
    Survey response — 3 months, dose 2, under 3
    MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school
    Free text: A cold
    MedDRA releases: 2024-11 · check-in free text available
  18. 2023-01-19
    Survey response — 6 months, dose 2, under 3
    MedDRA: Respiratory syncytial virus infection — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  19. 2023-01-19
    Report sent to call center — 6 months, dose 2, under 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  20. 2023-01-20
  21. 2023-01-20

Vaccinations

DoseDateManufacturerCo-administered
12022-06-23Moderna No
22022-07-21Moderna No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 12 (Under 3) — 3 months, dose 2, under 3

2022-10-20

Symptoms: A cold

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDNasopharyngitis · · ✓
SDRespiratory syncytial virus infection · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…